These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 33432062

  • 1. Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8+ T and NK cell function.
    Xun Z, Lin J, Yu Q, Liu C, Huang J, Shang H, Guo J, Ye Y, Wu W, Zeng Y, Wu S, Xu S, Chen T, Chen J, Ou Q.
    Cell Mol Immunol; 2021 Feb; 18(2):461-471. PubMed ID: 33432062
    [Abstract] [Full Text] [Related]

  • 2. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L, Cai YJ, Yu L, Feng JY, Wang J, Li C, Niu JQ, Jiang YF.
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
    [Abstract] [Full Text] [Related]

  • 3. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.
    Micco L, Peppa D, Loggi E, Schurich A, Jefferson L, Cursaro C, Panno AM, Bernardi M, Brander C, Bihl F, Andreone P, Maini MK.
    J Hepatol; 2013 Feb; 58(2):225-33. PubMed ID: 23046671
    [Abstract] [Full Text] [Related]

  • 4. [Effect of tenofovir disoproxil fumarate antiviral therapy on virus-specific CD8+T Cells function in patients with chronic hepatitis B].
    Duan SP, Zhu LH, Hou LJ, Wang HW, Zhu XW, Hao J.
    Zhonghua Gan Zang Bing Za Zhi; 2021 May 20; 29(5):421-426. PubMed ID: 34107578
    [Abstract] [Full Text] [Related]

  • 5. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S, Nandi M, Pal S, Mukhopadhyay D, Chakraborty BC, Khatun M, Bhowmick D, Mondal RK, Das S, Das K, Ghosh R, Banerjee S, Santra A, Chatterjee M, Chowdhury A, Datta S.
    Clin Microbiol Infect; 2016 Aug 20; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [Abstract] [Full Text] [Related]

  • 6. CD56bright natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long-term entecavir-treated patients switching to peginterferon alfa-2a.
    Shi A, Zhang X, Xiao F, Zhu L, Yan W, Han M, Luo X, Chen T, Ning Q.
    J Viral Hepat; 2018 Nov 20; 25(11):1352-1362. PubMed ID: 29888839
    [Abstract] [Full Text] [Related]

  • 7. TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.
    Lai Q, Ma S, Ge J, Huang Z, Huang X, Jiang X, Li Y, Zhang M, Zhang X, Sun J, Abbott WG, Hou J.
    PLoS One; 2014 Nov 20; 9(2):e88475. PubMed ID: 24551107
    [Abstract] [Full Text] [Related]

  • 8. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
    Gu Y, Lian Y, Zheng Q, Huang Z, Gu L, Bi Y, Li J, Huang Y, Wu Y, Chen L, Huang Y.
    BMC Infect Dis; 2020 Jul 14; 20(1):509. PubMed ID: 32664850
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
    Stelma F, de Niet A, Tempelmans Plat-Sinnige MJ, Jansen L, Takkenberg RB, Reesink HW, Kootstra NA, van Leeuwen EM.
    J Infect Dis; 2015 Oct 01; 212(7):1042-51. PubMed ID: 25791117
    [Abstract] [Full Text] [Related]

  • 11. Higher BST2 Expression Promotes the Anti-HBV Effect of IFN-α and BST2 Genetic Variant Predicts PegIFNα Treatment Response of HBeAg-Positive Chronic Hepatitis B Patients.
    Chen J, Hou J, Na R, Zhou B, Hou J, Jiang DK.
    Clin Pharmacol Ther; 2024 Feb 01; 115(2):361-370. PubMed ID: 38018367
    [Abstract] [Full Text] [Related]

  • 12. Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg.
    Liu N, Liu B, Zhang L, Li H, Chen Z, Luo A, Chen M, Peng M, Yin W, Ren H, Hu P.
    Int Immunopharmacol; 2018 Sep 01; 62():59-66. PubMed ID: 29990695
    [Abstract] [Full Text] [Related]

  • 13. Upregulation of NKG2C+ natural killer cells, TLR-2 expression on monocytes and downregulation of regulatory T-cells influence PEG-IFN treatment efficacy in entecavir-suppressed patients with CHB.
    Yan W, Wu D, Wang X, Chen T, Lai Q, Zheng Q, Jiang J, Hou J, Han M, Ning Q.
    Antivir Ther; 2015 Sep 01; 20(6):591-602. PubMed ID: 25814467
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection.
    Yang F, Yu X, Zhou C, Mao R, Zhu M, Zhu H, Ma Z, Mitra B, Zhao G, Huang Y, Guo H, Wang B, Zhang J.
    PLoS Pathog; 2019 Apr 01; 15(4):e1007690. PubMed ID: 30998767
    [Abstract] [Full Text] [Related]

  • 15. Boosting of Hepatitis B Virus-Specific T Cell Responses After Pegylated-Interferon-α-2a Therapy for Hepatitis B e Antigen-Positive Pediatric Patients.
    Ning L, Huang X, Xu Y, Yang G, Yang J, Fu Q, Zhang Q, Liu H, Wu X, Wang Z, Luo K.
    J Interferon Cytokine Res; 2019 Dec 01; 39(12):740-751. PubMed ID: 31329012
    [Abstract] [Full Text] [Related]

  • 16. Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B.
    Tjwa ET, Zoutendijk R, van Oord GW, Biesta PJ, Verheij J, Janssen HL, Woltman AM, Boonstra A.
    Liver Int; 2014 Mar 01; 34(3):396-404. PubMed ID: 23890390
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro.
    Chen M, Hu P, Ling N, Peng H, Lei Y, Hu H, Zhang D, Ren H.
    PLoS One; 2015 Mar 01; 10(3):e0120086. PubMed ID: 25774808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.